Masimo (MASI) EGM 2026 summary
Event summary combining transcript, slides, and related documents.
EGM 2026 summary
15 May, 2026Opening remarks and agenda
Meeting called to order by CEO, with recording available for replay for one week.
Inspector of Election appointed and sworn in; voting instructions provided for virtual attendees.
CEO expressed gratitude to shareholders and employees, highlighting achievements and strategic direction.
Meeting held pursuant to notice sent to all stockholders of record as of March 31, 2026.
Specific resolutions to be voted on
Approval of merger agreement with Danaher Corporation and Mobius Merger Sub, Inc.
Advisory vote on compensation for named executive officers in connection with the merger.
Board and executive committee updates
CEO reflected on tenure, strategic focus on core healthcare business, and leadership team expansion.
Noted exceeding 2025 earnings targets and successful transaction benefiting stakeholders.
Latest events from Masimo
- Shareholders to vote on $180 per share Danaher merger, with board support and litigation addressed.MASI
Proxy filing - Shareholders to vote on $180/share all-cash merger with Danaher and related executive compensation.MASI
Proxy filing - Stockholders to vote on $180/share Danaher acquisition, with board unanimous support and premium offered.MASI
Proxy Filing - $1B credit facility signed in Dec 2025 with leverage and coverage covenants, maturing 2030.MASI
Q4 2025 - Masimo to be acquired by Danaher for $180 per share, pending shareholder approval.MASI
Proxy Filing - Board approves $180/share Danaher acquisition; shareholder vote and regulatory review pending.MASI
Proxy Filing - Shareholders will vote on a $180/share all-cash merger, with closing expected in late 2026.MASI
Proxy Filing - Q3 revenue up 5% to $504.6M, with healthcare growth and raised EPS guidance for 2024.MASI
Q3 2024 - Q4 and 2024 saw strong revenue and margin growth, with 8–11% healthcare growth expected in 2025.MASI
Q4 2024